Medical News

RSS

Montefiore-Einstein selected to conduct multi-site cancer clinical trials

Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine of Yeshiva University have been awarded a $3.4 million grant from the National Cancer Institute to conduct multi-site cancer clinical trials and research focused on reducing healthcare disparities in cancer care.

29 Sep 2014

CVS to pay $6M to settle Medicaid reimbursement case

Caremark LLC, a unit of CVS, will make the payments to settle allegations that it knowingly failed to reimburse Medicaid for prescription drug costs paid on behalf of patients who were also covered by private plans it administered. The company denied wrongdoing.

29 Sep 2014

Christiana Care Health System wins 2014 Health Devices Achievement Award

ECRI Institute is pleased to announce Christiana Care Health System, Wilmington, DE, as the winner of its 9th Annual Health Devices Achievement Award.

29 Sep 2014

Arisaph Pharmaceuticals receives STTR grants to develop cancer drug candidates

Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.

29 Sep 2014

Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

Galmed Pharmaceuticals Ltd. ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT™ devices and accessories from Itamar Medical Ltd.

29 Sep 2014

Avanir Pharmaceuticals closes public offering of 20,930,000 shares of common stock

Avanir Pharmaceuticals, Inc. today announced the closing of its previously announced public offering of 20,930,000 shares of its common stock, including 2,730,000 shares sold pursuant to the underwriters' full exercise of their option to purchase additional shares, at a price to the public of $11.00 per share, before underwriting discounts.

29 Sep 2014

Manzo Pharmaceuticals reports successful testing of lactase producing probiotic, Lacto-Freedom

Manzo Pharmaceuticals, Inc., today announced at the three month mark in a six month animal study, that the results of the lactase producing probiotic, Lacto-Freedom™, has been very successful.

29 Sep 2014

Spring Mountain Capital leads financing round for Oncoceutics with additional private investors' participation

Spring Mountain Capital, LP, a New York-based investment management firm, announced today that its private equity group structured and led a financing round for Oncoceutics, Inc. with additional private investors' participation.

29 Sep 2014

HerKare opens new location in Mansfield, Texas

HerKare opens a new location today in Mansfield, Texas. This marks HerKare's third center in Dallas-Fort Worth. HerKare recently expanded to Houston area and continues to accelerate their growth plans, making the treatment of hormonal imbalance in women more convenient.

29 Sep 2014

HealthCare.com launches new health insurance comparison website

HealthCare.com announces the launch of its new health insurance comparison website that gives consumers more choices to research, shop and buy healthcare plans, which could lead to lowering insurance costs for millions of Americans.

29 Sep 2014

Protein Sciences releases Flublok influenza vaccine for the 2014/2015 season

Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been released and are now available for shipment.

29 Sep 2014

Raritan Bay Medical Center accepts customer service inquiries via Twitter

Raritan Bay Medical Center announces it will begin to accept customer service inquiries via Twitter, the social media website.

29 Sep 2014

Curemark Founder to get Northstar Award for breakthrough autism research

Curemark, a leading drug research and development company focused on the treatment of neurological and other diseases, is proud to announce that Dr. Joan Fallon, Founder and CEO, will receive Springboard Enterprises' Northstar Award, as recognition for her entrepreneurial leadership and achievements in autism research.

29 Sep 2014

Civitis Solutions acquires Mass Adult Day Health Alliance

The Mass Adult Day Health Alliance, the largest provider of adult day health programs for elders in Massachusetts, announced today that it has been acquired by Civitis Solutions Inc., a national organization of local health and human services providers that markets its services under the name The MENTOR Network.

29 Sep 2014

Docs express frustration with electronic health records

And some worry that a slate of new Web domain addresses could trick consumers into taking medical advice from and getting scammed by those without the proper credentials.

29 Sep 2014

Cumulative noise exposure can cause hearing loss in teachers

Ringing bells, slamming lockers, loud announcements, chattering students – the classic sounds of back-to-school are not always music to the ears of today's teachers.

29 Sep 2014

Viewpoints: Hospitals helped by Medicaid expansion; why GOP candidates back OTC contraceptives

Now the Department of Health and Human Services has issued a report showing that ... thanks to the Affordable Care Act, hospitals across the country will save $5.7 billion in uncompensated care costs in 2014.

29 Sep 2014

Cantel Medical achieves record revenue growth in fourth quarter 2014

CANTEL MEDICAL CORP. reported net income of $10,705,000, or $0.26 per diluted share, on a 15% increase in sales to a record $131,377,000 for the fourth quarter ended July 31, 2014, inclusive of $0.02 for charges related to acquisition and CFO retirement costs.

29 Sep 2014

Tianyin Pharmaceutical's Qionglai Facility completes official GMP site visit by CFDA

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that its Qionglai Facility (QLF) has successfully completed the official site visit by the China Food & Drug Administration's (CFDA) for its Good Manufacturing Practice (GMP) certification.

29 Sep 2014

Bigger challenges forecast for health law's second enrollment drive

Enrolling new customers will be more complicated this time around because potential enrollees may be harder to reach, reports The Wall Street Journal.

29 Sep 2014